Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jan;29(1):e13185.
doi: 10.1111/ecc.13185. Epub 2019 Nov 6.

Optimising pharmacotherapy in older cancer patients with polypharmacy

Affiliations

Optimising pharmacotherapy in older cancer patients with polypharmacy

Elze Vrijkorte et al. Eur J Cancer Care (Engl). 2020 Jan.

Abstract

Objective: Polypharmacy is frequent among older cancer patients and increases the risk of potential drug-related problems (DRPs). DRPs are associated with adverse drug events, drug-drug interactions and hospitalisations. Since no standardised polypharmacy assessment methods for oncology patients exist, we aimed to develop one that can be integrated into routine care.

Methods: Based on the Systematic Tool to Reduce Inappropriate Prescribing (STRIP), we developed OncoSTRIP, which includes a polypharmacy anamnesis, a concise geriatric assessment, a polypharmacy analysis taking life expectancy into account and an optimised treatment plan. Patients ≥65 years with ≥5 chronic drugs visiting our outpatient oncology clinic were eligible for the polypharmacy assessment.

Results: OncoSTRIP was integrated into routine care of our older cancer patients. In 47 of 60 patients (78%), potential DRPs (n = 101) were found. In total, 85 optimisations were recommended, with an acceptance rate of 41%. It was possible to reduce the number of potential DRPs by 41% and the number of patients with at least one potential DRP by 30%. Mean time spent per patient was 71 min.

Conclusions: Polypharmacy assessment of older cancer patients identifies many pharmacotherapeutic optimisations. With OncoSTRIP, polypharmacy assessments can be integrated into routine care.

Keywords: cancer; deprescribing; drug-related problems; geriatrics; medication assessment; polypharmacy.

PubMed Disclaimer

Conflict of interest statement

None to declare.

References

    1. American Geriatrics Society (2015). Beers criteria update expert panel (2015). American geriatrics society 2015 updated beers criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 63, 2227–2246. 10.1111/jgs.13702 - DOI - PubMed
    1. Beers, M. H. , Ouslander, J. G. , Rollingher, I. , Reuben, D. B. , Brooks, J. , & Beck, J. C. (1991). Explicit criteria for determining inappropriate medication use in nursing home. UCLA division of geriatric medicine. Archives of Internal Medicine, 151, 1825–1832. 10.1001/archinte.1991.00400090107019 - DOI - PubMed
    1. Bellera, C. A. , Rainfray, M. , Mathoulin‐Pélissier, S. , Mertens, C. , Delva, F. , Fonck, M. , & Soubeyran, P. L. (2012). Screening older cancer patients: First evaluation of the G‐8 geriatric screening tool. Annals of Oncology, 23, 2166–2172. 10.1093/annonc/mdr587 - DOI - PubMed
    1. Dutch General Practitioners, Dutch Geriatric Society, Dutch Order of Medical Specialists (2012). Multidisciplinary Guideline Polypharmacy in the Elderly (Multidisciplinaire Richtlijn Polyfarmacie bij ouderen). Utrecht, the Netherlands: NHG.
    1. Ferlay, J. , Soerjomataram, I. , Ervik, M. , Dikshit, R. , Eser, S. , Mathers, C. , Bray, F. (2013). GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012 v1.0. IARC CancerBase No. 11. Retrieved from http://globocan.iarc.fr [accessed 20 Jun. 2017].